secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIGAND PHARMACEUTICALS INC (LGND)
CIK:        0000886163
Form:       8-K
Filed at:   2025-12-18T23:59:59+00:00
Accession:  0001193125-25-324830
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Ligand discloses private placement investment in Athira Pharma
--------------------------------------------------------------

- Private placement investment in Athira Pharma, Inc. announced via social media and IR page.
- No financial terms, size, or pricing disclosed in the 8-K filing.
- Ligand directs investors to its website and social media for further details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886163/000119312525324830/0001193125-25-324830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886163/000119312525324830/d938301d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-324830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer